-
Something wrong with this record ?
Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy
R. Sari Motlagh, K. Mori, A. Aydh, PI. Karakiewicz, QD. Trinh, SF. Shariat,
Language English Country United States
Document type Journal Article
- MeSH
- Surgeons psychology MeSH
- Cystectomy * MeSH
- Humans MeSH
- Lymph Node Excision * MeSH
- Urinary Bladder Neoplasms surgery MeSH
- Hospitals, High-Volume * MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
PURPOSE OF REVIEW: There is heightened awareness and trends towards centralizing high-risk, complex surgeries such as radical cystectomy to minimize complications and improve survival. However, after nearly a decade of mandated and/or passive centralization of care, debate regarding its benefits and harms continues. RECENT FINDINGS: During the past decade, mandated and passive centralization has led to an increase in radical cystectomies performed in high-volume hospitals (HVHs) and, perhaps by high-volume surgeons (HVS), in addition to efforts to increase the uptake of multidisciplinary strategies in the management of radical cystectomy patients. Consequently, 30 and 90-day mortality rates and overall survival have improved, and major complications and transfusion rates have decreased. Factors impacting surgical quality, such as negative surgical margin(s), pelvic lymphadenectomy and/or lymph node yield rates have increased. However, current studies have not demonstrated a coadditive impact of centralization on oncological outcomes (i.e. cancer-specific and recurrence-free survival). The benefits of centralization on oncologic survival of radical cystectomy remain unclear given the varied definitions of HVHs and HVSs across studies. In fact, centralization of radical cystectomy could lead to an increase in patient load in HVHs and for HVSs, thereby leading to longer surgery waiting times, a factor that is important in the management of muscle-invasive bladder cancer. SUMMARY: The benefits of centralization of radical cystectomy with multidisciplinary management are shown increasingly and convincingly. More studies are necessary to prospectively test the benefits, risks and harms of centralization.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027874
- 003
- CZ-PrNML
- 005
- 20210114152531.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MOU.0000000000000805 $2 doi
- 035 __
- $a (PubMed)32732625
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sari Motlagh, Reza $u Department of Urology, Medical University of Vienna, Vienna, Austria.
- 245 10
- $a Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy / $c R. Sari Motlagh, K. Mori, A. Aydh, PI. Karakiewicz, QD. Trinh, SF. Shariat,
- 520 9_
- $a PURPOSE OF REVIEW: There is heightened awareness and trends towards centralizing high-risk, complex surgeries such as radical cystectomy to minimize complications and improve survival. However, after nearly a decade of mandated and/or passive centralization of care, debate regarding its benefits and harms continues. RECENT FINDINGS: During the past decade, mandated and passive centralization has led to an increase in radical cystectomies performed in high-volume hospitals (HVHs) and, perhaps by high-volume surgeons (HVS), in addition to efforts to increase the uptake of multidisciplinary strategies in the management of radical cystectomy patients. Consequently, 30 and 90-day mortality rates and overall survival have improved, and major complications and transfusion rates have decreased. Factors impacting surgical quality, such as negative surgical margin(s), pelvic lymphadenectomy and/or lymph node yield rates have increased. However, current studies have not demonstrated a coadditive impact of centralization on oncological outcomes (i.e. cancer-specific and recurrence-free survival). The benefits of centralization on oncologic survival of radical cystectomy remain unclear given the varied definitions of HVHs and HVSs across studies. In fact, centralization of radical cystectomy could lead to an increase in patient load in HVHs and for HVSs, thereby leading to longer surgery waiting times, a factor that is important in the management of muscle-invasive bladder cancer. SUMMARY: The benefits of centralization of radical cystectomy with multidisciplinary management are shown increasingly and convincingly. More studies are necessary to prospectively test the benefits, risks and harms of centralization.
- 650 12
- $a cystektomie $7 D015653
- 650 12
- $a specializovaná centra se zvyšujícím se počtem výkonů a tím zvyšující se kvalitou léčby $7 D061847
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a lymfadenektomie $7 D008197
- 650 _2
- $a chirurgové $x psychologie $7 D066231
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a nádory močového měchýře $x chirurgie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mori, Keiichiro $u Department of Urology, Medical University of Vienna, Vienna, Austria. Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
- 700 1_
- $a Aydh, Abdulmajeed $u Department of Urology, Medical University of Vienna, Vienna, Austria. Department of Urology, King Faisal Medical City, Abha, Saudi Arabia.
- 700 1_
- $a Karakiewicz, Pierre I $u Cancer Prognostics and Health outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
- 700 1_
- $a Trinh, Quoc-Dien $u Division of Urological Surgery and Center for Surgery and Public Health, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, Vienna, Austria. Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan. Department of Urology, Weil Cornell Medical College, New York, New York. Department of Urology, University of Texas Southwestern, Dallas, Texas, USA. Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. European Association of Urology Research Foundation, Arnhem, the Netherlands.
- 773 0_
- $w MED00001296 $t Current opinion in urology $x 1473-6586 $g Roč. 30, č. 5 (2020), s. 701-710
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32732625 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152529 $b ABA008
- 999 __
- $a ok $b bmc $g 1608209 $s 1119054
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 30 $c 5 $d 701-710 $e - $i 1473-6586 $m Current opinion in urology $n Curr Opin Urol $x MED00001296
- LZP __
- $a Pubmed-20210105